BG103219A - Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие - Google Patents
Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действиеInfo
- Publication number
- BG103219A BG103219A BG103219A BG10321999A BG103219A BG 103219 A BG103219 A BG 103219A BG 103219 A BG103219 A BG 103219A BG 10321999 A BG10321999 A BG 10321999A BG 103219 A BG103219 A BG 103219A
- Authority
- BG
- Bulgaria
- Prior art keywords
- ltb
- application
- benzamidine derivatives
- antagonist effect
- medicamentous forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyrane Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Изобретението се отнася до нови бензамидинови производни с формула, в която заместителите имат значения, посочени в описанието, до методза тяхното получаване и до използването им в медицината.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19636689A DE19636689A1 (de) | 1996-09-10 | 1996-09-10 | Neue Benzamidinderivate |
PCT/EP1997/004921 WO1998011062A1 (de) | 1996-09-10 | 1997-09-09 | Benzamidinderivate und ihre verwendung als arzneimittel mit ltb4-antagonistischer wirkung |
Publications (2)
Publication Number | Publication Date |
---|---|
BG103219A true BG103219A (bg) | 1999-10-29 |
BG63938B1 BG63938B1 (bg) | 2003-07-31 |
Family
ID=7805125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG103219A Active BG63938B1 (bg) | 1996-09-10 | 1999-03-01 | Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие |
Country Status (31)
Country | Link |
---|---|
US (2) | US6197824B1 (bg) |
EP (2) | EP0929516B1 (bg) |
JP (2) | JP4150427B2 (bg) |
KR (1) | KR20000036005A (bg) |
CN (1) | CN1104412C (bg) |
AR (1) | AR009741A1 (bg) |
AT (2) | ATE266630T1 (bg) |
AU (1) | AU727900B2 (bg) |
BG (1) | BG63938B1 (bg) |
BR (1) | BR9712816A (bg) |
CA (1) | CA2262566C (bg) |
CO (1) | CO4900032A1 (bg) |
CZ (1) | CZ297252B6 (bg) |
DE (3) | DE19636689A1 (bg) |
DK (1) | DK0929516T3 (bg) |
EA (1) | EA003245B1 (bg) |
EE (1) | EE04431B1 (bg) |
ES (1) | ES2184131T3 (bg) |
HK (1) | HK1020564A1 (bg) |
HU (1) | HUP9904367A3 (bg) |
IL (1) | IL128144A (bg) |
NO (1) | NO312239B1 (bg) |
NZ (1) | NZ334895A (bg) |
PL (1) | PL188012B1 (bg) |
PT (1) | PT929516E (bg) |
SK (1) | SK282432B6 (bg) |
TR (1) | TR199900501T2 (bg) |
TW (1) | TW378200B (bg) |
UA (1) | UA60315C2 (bg) |
WO (1) | WO1998011062A1 (bg) |
ZA (1) | ZA978045B (bg) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE274491T1 (de) | 1998-12-14 | 2004-09-15 | Hoffmann La Roche | Phenylglycin-derivate |
DE19948428A1 (de) * | 1999-10-07 | 2001-04-12 | Boehringer Ingelheim Pharma | Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel |
US6291531B1 (en) * | 1999-10-07 | 2001-09-18 | Boehringer Ingelheim Pharma Kg | LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition |
DE10052658A1 (de) * | 2000-10-24 | 2002-05-02 | Boehringer Ingelheim Pharma | Neue Pyranosidderivate |
US6528491B2 (en) | 2000-10-24 | 2003-03-04 | Boehringer Ingelheim Pharma Kg | Pyranoside derivatives |
US6489359B2 (en) | 2000-10-24 | 2002-12-03 | Boehringer Ingelheim Pharma Kg | Sulphoxybenzamides |
DE10052333A1 (de) * | 2000-10-24 | 2002-05-02 | Boehringer Ingelheim Pharma | Neue Sulfooxybenzamide |
US7776315B2 (en) * | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
US6608054B2 (en) * | 2001-03-20 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics and endothelin antagonists |
AU4239302A (en) * | 2001-06-28 | 2003-01-02 | Pfizer Products Inc. | Benzoic acid substituted benzopyrans for the treatment of atherosclerosis |
US20030119901A1 (en) * | 2001-07-14 | 2003-06-26 | Boehringer Ingelheim Pharma Kg | Pharmaceutical formulation containing an LTB4 antagonist |
JP2005502630A (ja) * | 2001-07-14 | 2005-01-27 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | Ltb4拮抗薬を含有する医薬製剤 |
BR0212078A (pt) * | 2001-08-31 | 2004-09-28 | Neurochem Int Ltd | Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto |
US6921752B2 (en) * | 2002-03-26 | 2005-07-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of LTB4 antagonists in veterinary medicine |
DE10213350A1 (de) * | 2002-03-26 | 2003-10-16 | Boehringer Ingelheim Pharma | Verwendung von LTB¶4¶Antagonisten in der Tiermedizin |
RS20050390A (en) * | 2002-11-26 | 2008-04-04 | Boehringer Ingelheim Pharma Gmbh. & Co.Kg., | Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor |
US7262223B2 (en) * | 2004-01-23 | 2007-08-28 | Neurochem (International) Limited | Amidine derivatives for treating amyloidosis |
WO2006004370A1 (en) * | 2004-07-05 | 2006-01-12 | Dong Wha Pharmaceutical. Ind. Co., Ltd. | Composition for the prevention and treatment of allergic inflammatory disease |
KR20060017929A (ko) * | 2004-08-04 | 2006-02-28 | 동화약품공업주식회사 | 티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물 |
US8679288B2 (en) * | 2008-06-09 | 2014-03-25 | Lam Research Corporation | Showerhead electrode assemblies for plasma processing apparatuses |
CN106831611B (zh) * | 2017-01-23 | 2019-06-21 | 北京化工大学 | 一种偕胺肟类化合物及其在制备抑制癌细胞增殖药的应用 |
JP7373191B2 (ja) | 2017-05-12 | 2023-11-02 | 国立研究開発法人理化学研究所 | クラスa gpcr結合性化合物改変体 |
CN113164567A (zh) * | 2018-09-24 | 2021-07-23 | 不列颠哥伦比亚大学 | 在治疗皮肤状况中调节颗粒酶k活性 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4102024A1 (de) | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
EP0518818A3 (en) * | 1991-06-11 | 1993-04-28 | Ciba-Geigy Ag | Arylethers, their manufacture and use as medicament |
US5246965A (en) | 1991-06-11 | 1993-09-21 | Ciba-Geigy | Arylethers, their manufacture and methods of treatment |
ES2165122T3 (es) * | 1992-02-05 | 2002-03-01 | Boehringer Ingelheim Pharma | Nuevos derivados de amidina, su preparacion y utilizacion como medicamentos con efecto antagonista de ltb4. |
DE4219158A1 (de) * | 1992-06-11 | 1993-12-16 | Thomae Gmbh Dr K | Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
DE4424713A1 (de) * | 1994-07-13 | 1996-01-18 | Boehringer Ingelheim Kg | Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe |
DE4424714A1 (de) * | 1994-07-13 | 1996-01-18 | Boehringer Ingelheim Kg | Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff |
DE19546452A1 (de) * | 1995-12-13 | 1997-06-19 | Boehringer Ingelheim Kg | Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel |
-
1996
- 1996-09-10 DE DE19636689A patent/DE19636689A1/de not_active Withdrawn
-
1997
- 1997-09-08 ZA ZA9708045A patent/ZA978045B/xx unknown
- 1997-09-09 EE EEP199900086A patent/EE04431B1/xx not_active IP Right Cessation
- 1997-09-09 AT AT02003690T patent/ATE266630T1/de not_active IP Right Cessation
- 1997-09-09 CN CN97197748A patent/CN1104412C/zh not_active Expired - Fee Related
- 1997-09-09 CO CO97052335A patent/CO4900032A1/es unknown
- 1997-09-09 AU AU43838/97A patent/AU727900B2/en not_active Ceased
- 1997-09-09 UA UA99042008A patent/UA60315C2/uk unknown
- 1997-09-09 TW TW086113036A patent/TW378200B/zh not_active IP Right Cessation
- 1997-09-09 AT AT97942007T patent/ATE224363T1/de active
- 1997-09-09 EP EP97942007A patent/EP0929516B1/de not_active Expired - Lifetime
- 1997-09-09 NZ NZ334895A patent/NZ334895A/xx not_active IP Right Cessation
- 1997-09-09 CZ CZ0082299A patent/CZ297252B6/cs not_active IP Right Cessation
- 1997-09-09 WO PCT/EP1997/004921 patent/WO1998011062A1/de active IP Right Grant
- 1997-09-09 BR BR9712816-3A patent/BR9712816A/pt not_active IP Right Cessation
- 1997-09-09 JP JP51324398A patent/JP4150427B2/ja not_active Expired - Fee Related
- 1997-09-09 HU HU9904367A patent/HUP9904367A3/hu unknown
- 1997-09-09 SK SK296-99A patent/SK282432B6/sk not_active IP Right Cessation
- 1997-09-09 IL IL12814497A patent/IL128144A/en not_active IP Right Cessation
- 1997-09-09 DE DE59711625T patent/DE59711625D1/de not_active Expired - Lifetime
- 1997-09-09 DE DE59708278T patent/DE59708278D1/de not_active Expired - Lifetime
- 1997-09-09 PL PL33213697A patent/PL188012B1/pl not_active IP Right Cessation
- 1997-09-09 PT PT97942007T patent/PT929516E/pt unknown
- 1997-09-09 KR KR1019997001964A patent/KR20000036005A/ko not_active Application Discontinuation
- 1997-09-09 DK DK97942007T patent/DK0929516T3/da active
- 1997-09-09 EP EP02003690A patent/EP1203764B1/de not_active Expired - Lifetime
- 1997-09-09 ES ES97942007T patent/ES2184131T3/es not_active Expired - Lifetime
- 1997-09-09 US US09/242,389 patent/US6197824B1/en not_active Expired - Lifetime
- 1997-09-09 EA EA199900279A patent/EA003245B1/ru not_active IP Right Cessation
- 1997-09-09 TR TR1999/00501T patent/TR199900501T2/xx unknown
- 1997-09-09 CA CA002262566A patent/CA2262566C/en not_active Expired - Fee Related
- 1997-09-10 AR ARP970104148A patent/AR009741A1/es active IP Right Grant
-
1999
- 1999-03-01 BG BG103219A patent/BG63938B1/bg active Active
- 1999-03-09 NO NO19991131A patent/NO312239B1/no not_active IP Right Cessation
- 1999-12-02 HK HK99105613A patent/HK1020564A1/xx not_active IP Right Cessation
-
2000
- 2000-12-01 US US09/728,856 patent/US6265612B1/en not_active Expired - Lifetime
-
2008
- 2008-04-16 JP JP2008107036A patent/JP4288299B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG103219A (bg) | Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие | |
BG103251A (bg) | Оксадиазоли, методи за получаването им и приложението им като лекарствени средства | |
BG101193A (bg) | Нови заместени оксазолидинони | |
BG101194A (bg) | Нови хетероарилови оксазолидинони | |
BG101139A (bg) | Съдържащи хетероатоми циклопентанопиридилоксазолидинони | |
BG101131A (bg) | 2-оксо- и 2-тио-1,2-дихидрохинолинилоксазолидинони | |
BG104812A (bg) | Нови дихидропиримидини | |
PL340890A1 (en) | Adamantane derivatives | |
PL340906A1 (en) | Adamantane derivatives | |
ES2020890A6 (es) | Procedimiento de preparacion de una composicion farmaceutica en forma de microparticulas. | |
BG104056A (bg) | Триазолови съединения и използването им като допамин-d3-лиганди | |
IL124674A0 (en) | Piperazine derivatives pharmaceutical compositions containing the same and use thereof | |
SE9704546D0 (sv) | Novel compounds | |
BG102616A (bg) | Заместени аза- и диазациклохептанови и циклооктанови производни и използването им | |
BG103096A (bg) | Инхибитори на тромбин | |
BG102362A (bg) | Нови производни на аминокиселини, тяхното получаване и използване | |
GB2288183B (en) | Composition and method of preparing microemulsion blends | |
BG102395A (bg) | Нови фениламидинови производни, метод за тяхното получаване и приложението им като лекарствени средства | |
MY128260A (en) | Cyclopentane-and-pentene-b-amino acids | |
BG104291A (bg) | 3-заместени тетрахидропиридопиримидинонови производни, тяхното получаване и използване | |
AU8332791A (en) | Oral pharmaceutical compositions containing melatonin | |
BG104232A (bg) | Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства | |
AU1227699A (en) | Oxyranyle-triazoline thiones and their use as microbicides | |
BG102770A (bg) | Нови производни на карбоксилни киселини, тяхното получаване и използване | |
BG102771A (bg) | Нови диарилметилиденфуранови производни, метод за тяхното получаване и използването им като лекарствени средства |